Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids
Abstract Hepatoblastoma, the most prevalent pediatric liver cancer, almost always carries a WNT-activating CTNNB1 mutation, yet exhibits notable molecular heterogeneity. To characterize this heterogeneity and identify novel targeted therapies, we perform comprehensive analysis of hepatoblastomas and...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2024-11-01
|
| シリーズ: | Nature Communications |
| オンライン・アクセス: | https://doi.org/10.1038/s41467-024-52757-w |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
